Inhibitor Report for: Cpd17-Tacrine-5-HT6
| Cpd17-Tacrine-5-HT6 | Type (8) |
|---|
| Chemical_Nomenclature | N1-(2-((1-(phenylsulfonyl)-1H-indol-4-yl)oxy)ethyl)-N2-(1,2,3,4-tetrahydroacridin-9-yl)ethane-1,2-diamine |
| Formula | C31H32N4O3S |
| MW | 540.67 |
|  |
| Paper | Wichur_2021_Eur.J.Med.Chem_225_113783 |
| Comment | reversible inhibitor of acetyl- and butyrylcholinesterase (IC50 = 8 nM and IC50 = 24 nM respectively). Inhibit aggregation of amyloid-beta in vitro 75% at 10 microM. 5-HT6R antagonist Ki 13 nM |
| Family | ACHE |
| | BCHE |
| InChIKey | ZJGZDAGZMPYZKM-UHFFFAOYSA-N |
| CanonicalSMILES | C1(=CC=CC2=C1C=C[N]2[S](=O)(=O)C3=CC=CC=C3)OCCNCCNC4=C6C(=NC5=CC=CC=C45)CCCC6 |
| InChI | InChI=1S/C31H32N4O3S/c36-39(37,23-9-2-1-3-10-23)35-21-17-26-29(35)15-8-16-30(26)38-22-20-32-18-19-33-31-24-11-4-6-13-27(24)34-28-14-7-5-12-25(28)31/h1-4,6,8-11,13,15-17,21,32H,5,7,12,14,18-20,22H2,(H,33,34) |
|
|
|
